Skip to main navigation Skip to search Skip to main content

Determination of ADC Concentration by Ligand-Binding Assays

  • SUNY Buffalo

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

9 Scopus citations

Abstract

Total antibody, conjugated antibody or antibody-conjugated drug, and free drug are key analytes required to establish exposure–response relationships for ADCs. Therefore, bioanalytical strategies for ADCs include ligand-binding assays (LBA) and LC–MS/MS methods. Here we describe detailed methodology to develop a solid-phase-based enzyme-linked immunosorbent assay (ELISA), which is the most widely used LBA to quantify large-molecule components of ADC in biological matrices such as plasma, serum, tumor, or tissue homogenates. The approach presented here is designed to quantify total antibody concentrations in ADC containing samples, and can be easily adapted to quantify conjugated antibody concentrations.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages361-369
Number of pages9
DOIs
StatePublished - 2020

Publication series

NameMethods in Molecular Biology
Volume2078
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • Antibody–drug conjugate (ADC)
  • Biodistribution
  • ELISA
  • Ligand-binding assay (LBA)
  • Pharmacokinetics (PK)
  • Sandwich ELISA

Fingerprint

Dive into the research topics of 'Determination of ADC Concentration by Ligand-Binding Assays'. Together they form a unique fingerprint.

Cite this